Cerebellum’s Booz Allen Hamilton BAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
$61K Sell
734
-2,573
-78% -$211K 0.28% 260
2020
Q2
$126K Buy
+3,307
New +$250K 0.09% 227
2019
Q4
$52K Sell
728
-5,468
-88% -$389K 0.03% 389
2019
Q3
$440K Buy
6,196
+4,772
+335% +$338K 0.28% 171
2019
Q2
$94K Buy
+1,424
New +$87.5K 0.08% 371
2019
Q1
Sell
-1,272
Closed -$57K 447
2018
Q4
$57K Sell
1,272
-2,307
-64% -$113K 0.04% 390
2018
Q3
$178K Sell
3,579
-559
-14% -$27.3K 0.28% 231
2018
Q2
$181K Sell
4,138
-881
-18% -$36.9K 0.3% 43
2018
Q1
$194K Buy
5,019
+1,712
+52% +$66.2K 0.25% 47
2017
Q4
$126K Buy
+3,307
New +$125K 0.09% 227

Other funds holding BAH

Cerebellum's BAH Position: Q3 2020 in Review

Cerebellum reduced its Booz Allen Hamilton (BAH) stake by 78% in Q3 2020, selling an estimated $211K and leaving 734 shares worth $61K. The position accounts for 0.28% of the portfolio, ranked #260.

Cerebellum first reported a position in BAH in Q4 2017 and has held it in 10 quarters since. The position peaked at $440K in Q3 2019. 502 funds tracked by Wall St. Rank hold BAH as of Q3 2020.

  • Cerebellum held 734 shares of Booz Allen Hamilton worth $61K as of Q3 2020.
  • Cerebellum sold 2,573 Booz Allen Hamilton shares in Q3 2020, an estimated $211K.
  • Booz Allen Hamilton made up 0.28% of Cerebellum's portfolio in Q3 2020, its #260 holding.
  • Cerebellum first reported a position in Booz Allen Hamilton in Q4 2017 and has held it in 10 quarters since.
  • Cerebellum's Booz Allen Hamilton position peaked at $440K in Q3 2019.
  • 502 funds tracked by Wall St. Rank held Booz Allen Hamilton as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.